Wednesday 1 November 2017

Hyaluronic acid market Expected to reach a value of USD 15.4 billion by 2025 : Grand View Research,Inc.

The global hyaluronic acid market was valued at USD 7.2 billion in 2016 and is expected to reach a value of USD 15.4 billion by 2025. Factors such as increasing concern of population regarding chemicals, desire to get quick and evident results, and shorter recovery time are high impact rendering drivers of this market.
The market is evolving rapidly due to the increasing adoption of aesthetic procedures in developed and developing regions. Increasing use of hyaluronic acid surfaces in cardiovascular implants, such as stents and vascular grafts, for improving the compatibility coupled with growing awareness about anti-aging products is fueling the growth. The efficacy and evident results of hyaluronic acid based dermal fillers are attracting this population base.
Moreover, a mounting number of obese people indicate the rising number of people suffering from orthopedic disorders. There does not exist any permanent cure for these disorders and treatment includes pain-killers. However, hyaluronic acid based viscosupplements are seen as a possible cure or at least a better option to joint pain. Orthovisc, approved in 2013, and Monovisc, approved in 2016, by Anika Therapeutics, Inc. are one of the popular viscosupplements.
Full Research Report on Global Genomics Market Analysis: 


Further Key Findings from the Study Suggest:
·         The rising obesity resulting in osteoarthritis and joint pain has increased the demand for hyaluronic acid injections as treatment. In 2012, 53 million people were sufferingfrom osteoarthritis and it is projected that by 2040, the number will grow to 78 million. This can be anticipated as the exponential demand for hyaluronic acid injections.
·         Cosmetic surgeries are booming with approximately 14 million minimally invasive procedures performed every year. In 2013, hyaluronan-based facial fillers received FDA approvalwhichis used in corrective measures,anti-aging procedure, and filling fine lines. These dermal fillers constitute a large share in these procedures and witnessed 8% growth in the year 2014.
·         In 2016, North America dominated the hyaluronic acid market. In 2009, viscosupplement Synvisc-One, by Genzyme Corporation received approval in U.S. and gained rapid popularity owing to its efficacy and ease of use. Increasing understanding of aging process coupled with the interest in dermal fillers boosted the demand for anti-aging procedures in this region. Presence of key players such as Genzyme Corporation and Anika Therapeutics in this region also contributes to aggressive marketing strategies of these companies fueling the customer awareness and acceptance.
·         Asia Pacific is anticipated to emerge as the fastest growing region during the forecast period. The growing geriatric population in China and Japan provides a large customer base for anti-aging products and services. Increasing awareness about applications of hyaluronan and its efficacy fuels the demand. In addition, stabilizing economies leaves the middle class population with surplus money to spend on these procedures.
·         Moreover, Asian population is influenced by western beauty standards and targets volumized appearance. This has resulted in growth of dermal filler market
·         The industry is presently dominated by few key participants such as F. Hoffmann-La Roche Ltd., Seikagaku Corporation, Galderma S.A, Sanofi (Genzyme), Anika Therapeutics Inc., Salix Pharmaceuticals, Zimmer Holdings Inc, Allergan Inc., Ferring Pharmaceuticals, Inc., and Smith & Nephew Plc.
Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/medical-devices
Grand View Research has segmented the hyaluronic acid market by application, and region:
Hyaluronic Acid Market Application Outlook (Market Revenue in USD Million, 2014 - 2025)
·         Dermal fillers
·         Osteoarthritis
·         Ophthalmic
·         Vesicoureteral reflux
OsteoarthritisMarket Product Outlook (Market revenue in USD Million, 2014 - 2025)
·         Single Injection
·         Three-injection
·         Five-injection
Hyaluronic Acid Market Regional Outlook (Market Revenue in USD Million, 2014 - 2025)
·         North America
o    U.S.
o    Canada
·         Europe
o    UK
o    Germany
·         Asia Pacific
o    Japan
o    China
·         Latin America
o    Brazil
o    Mexico
·         Middle East and Africa
o    South Africa

Access press release by Grand View Research : http://www.grandviewresearch.com/press-release/global-hyaluronic-acid-market
About Grand View Research 
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: www.grandviewresearch.com


at No comments:

Flexible Electronics Market projected to reach USD 87,210.0 million by 2024 : Grand View Research,Inc.

Global Flexible Electronics Market was USD 20,850.0 million in 2015, which is estimated to reach USD 87,210.0 million by 2024, according to a new report by Grand View Research, Inc. Escalating demand for compact and light-weight electronic devices is anticipated to fuel growth over the forecast period. Flexible batteries, displays, memories are a few products realized with the adoption of this technology. The technology provides ample opportunities in the area of smart textiles, which is the future of wearable’s. Government support in the form of funding that lends a helping hand to several research projects in this field is also anticipated to impact the industry growth positively.
Healthy demand for smart glasses, e-books, smartphones, smart watches, and e-papers is expected to catapult market growth over the next eight years. The technology facilitates electronic systems to be stretched, rolled, and flexed, minimizing design issues associated while developing compact, portable and miniature devices. The style and functionality of wearable devices is anticipated to witness a transition over the next eight years with companies such as Samsung, Apple, Nike and Google investing heavily in this segment, thereby providing avenues for discovering novel applications incorporating this technology.
Full Research Report on Global Flexible Electronics Market Analysis: 

Further key findings from the report suggest:
  • The consumer electronics segment accounted for over 55% of the overall revenue in 2015. The year 2014 witnessed the onset of new curved televisions, smartphones, and other electronic devices; a trend that gained traction in 2015, and is expected to impact the flexible electronics demand favorably from 2016 to 2024 owing to high penetration in the wearable’s segment
  • The display segment is projected to grow at a CAGR exceeding 16% over the forecast period. It is primarily attributed to the ability of these products to curve, roll, flex, conform and fold, enabling a new intuitive user interface. Further, companies are progressing towards the use of plastic displays as an alternative to glass displays, which provides opportunity for future growth
  • Wearable devices segment accounted for over 40% of the overall revenue in 2015 and is expected to witness a healthy demand over the forecast period. This increase is primarily ascribed to upsurge in demand for fitness or activity trackers as these products are well-positioned in the market with a promise of tracking productivity, physical activity, heart rate, sleep, etc. that intrigues customers
  • Asia Pacific flexible electronics market accounted for over 20% of the overall revenue share in 2015. Research capabilities and aggressive investments by major industry players such as LG and Samsung Electronics in anticipated to drive regional growth over the forecast period
  • Prominent industry participants include 3M, E Ink Holdings Inc., GE Measurement & Control Solutions, ITN Energy Systems Inc., LG, PARC, Samsung, and Thinfilm Electronics ASA. Strategic alliances among the major stakeholders such as material manufacturers, academia, and device integrators is anticipated to strengthen the existing technology know-how while driving drive efforts to explore new application areas
View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/electronic-devices
Grand View Research has segmented the Global Flexible Electronics Market on the basis of components, application and region:
Flexible Electronics Components Outlook (Revenue, USD Billion; 2013 - 2024)
  • Display
  • Battery
  • Sensors
  • Memory
  • Others
Flexible Electronics Application Outlook (Revenue, USD Billion; 2013 - 2024)
  • Consumer electronics
    • Television
    • Wearable devices
    • Smartphone
    • Others
  • Automotive
  • Healthcare
  • Industrial
  • Others
Flexible Electronics Regional Outlook (Revenue, USD Billion; 2013 - 2024)
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
View press release of this research report by Grand View Research: 

About Grand View Research 
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: www.grandviewresearch.com
at No comments:

Genomics Market Estimated to reach USD 22.1 billion by 2020 : Grand View Research,Inc.

Global Genomics Market is estimated to reach USD 22.1 billion by 2020, growing at an expected CAGR of 10.3% from 2014 to 2020. Genomics is a subunit of biology that is concerned with the study of genes and its functions and brings together the function and structure of genomes. Genomics is applied in several fields such as biotechnology, genomic medicine, anthropology, and various other social sciences. It consists of functional genomics, comparative genomics, pharmacogenomics, structural genomics, and epigenomics.
The global genomics market has undergone an increase in its market potential due to technological developments. Adding to it, factors including growing prevalence of fetal disorders such as diabetes and cancer, an increase in partial or full compensation by the government of certain countries add to the market’s growth across the globe.
In 2013, genomics-based diagnostics held the largest share of market revenue at over 35% on account of the occurrence of a considerably larger number of research & development initiatives. However, genomics-based personalized medicine segment is projected to have the highest growth rate, at an anticipated CAGR of over 12%, from 2014 to 2020. The high growth rate of the segment is on account of the growing demand for population-based therapeutic solutions and consequent increase in R&D initiatives.
Full Research Report on Global Genomics Market Analysis: 

Consumable led the global genomics market share at over 50% in 2013. This is on account of rising adoption rate of genomic testing for several applications, particularly in the field of drug development and discovery. The consumables segment is also expected to lead the market with the fastest growth rate over the forecast period owing to increasing applications and reduced costs of consumables.
In 2013, PCR technology had the largest market share of over 45% owing to technological developments and involvement of government policies about funding of research & development. Nucleic acid extraction and purification technology are expected to witness the highest growth rate, at a projected CAGR of 10.1%, from 2014 to 2020 on account of developing technologies for genome profiling and growing methods for new diagnostics tools and techniques.
North America was the major regional market, generating over 35% of the total revenue of the global genomics market. This was on account of various reasons such as high patient awareness levels, the presence of sophisticated infrastructure of healthcare. Asia Pacific is likely to be the highest growing region, at a projected CAGR of 12.7% over the next six years. The presence of large unmet medical needs and the increasing demand for economical clinical outsourcing in the emerging nations of China and India is anticipated to drive the high growth rate.
The major market players include Agilent Technologies, Bio-Rad Laboratories Inc., Illumina Inc., Roche Diagnostics, Cepheid, Affymetrix, Inc., BGI, GE Healthcare, Qiagen, and Life Technologies.
View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/biotechnology
Grand View Research has segmented the Global Genomics Market on the basis of product, application, technology and region:
Genomics Product Outlook

            • Instruments
            • Consumables
            • Services
Genomics Application Outlook 
            • Diagnostics
            • Personalized Medicines
            • Drug Discovery and Development
            • Academic Research
            • Agriculture
Genomics Technology Outlook 
            • PCR 
            • DNA Sequencing 
            • DNA Microarray 
            • Nucleic Acid Extraction and Purification 
Genomics Regional Outlook 
            • North America
            • Europe
            • Asia Pacific
            • RoW

View Blog On this research report by Grand View Research: 

About Grand View Research 
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: www.grandviewresearch.com





at No comments:

Vaccine Market projected to reach over USD 77.5 billion by 2024 : Grand View Research,Inc.

Global Vaccine Market is expected to reach over USD 77.5 billion by 2024, according to a new report by Grand View Research, Inc. The presence of numerous molecules in the pipeline is anticipated to meet the demand for efficient vaccines. These include vaccines for chest infection, tuberculosis, malaria, and dengue. Most of the key players are actively leveraging on their vaccine development technologies to launch novel preventative solutions with an objective to increase their market share. For instance, Pfizer, Inc. is involved in the development of vaccines to prevent severe infections caused by Meningococcal B, Clostridium difficile, and Staphylococcus aureus. 
Furthermore, the broad coalition of governments, worldwide, working to promote the awareness of vaccination benefits through immunization programs with the objective of containing the propagation of communicable diseases that are associated with high morbidity and mortality is expected to stimulate the market growth. 
For instance, the ‘Immunize Australia Program’ sponsors the immunization of individuals, which acts as a preventative action in preventing disease occurrence and checks rampant disease transmission thus protecting millions of Australians from severe diseases. Another program that has been involved in achieving extensive immunization coverage on the Indian continent is the National Immunization Program, a government program that has focused on taking strong preventive measures to offset vaccine-preventable diseases, particularly in children.  
Full Research Report on Global Vaccine Market Analysis: 

Further key findings from the study suggest:
  • The inactivated vaccine type segment was estimated to have over 14.5% market share in 2015 owing to the related advantages including easy storage and transport due to the highly stable nature of these vaccines. In December 2015, Sanofi Pasteur, Inc. launched a new trivalent, inactivated polio vaccine in India.
  • The DNA vaccine segment is presumed to be the fastest growing type over the forecast period owing to the ease of production compared to the cell-based vaccines and the promising, targeted immunization outcomes coupled with the continual developments in the biotechnology area. Other advantages associated are ease of production, long lasting immunogenicity, and no risk of reversion.
  • The cancer application segment is expected to witness the fastest growth with a CAGR of over 11.8% in the vaccinations market majorly attributable to the need for immunization against cancer coupled with the increasing prevalence of various types of cancer, such as cervical and colorectal cancers.
  • North America dominated the market in terms of revenue with over USD 12 billion in 2015, due mainly to the presence of extensive research and development activities and the existence of key participants of the industry in this region
  • Asia Pacific is identified to witness a lucrative growth with a CAGR of around 10.7% during the forecast period due to the growing population base and the increasing economic growth of countries, such as China, Japan, and India. Moreover, the availability of skilled labors at a lower cost and the low manufacturing operations cost provide a platform for clinical trial outsourcing of the vaccinations under development to expedite commercialization.
  • Leading players in this industry, among others are, Merck & Co., Inc., Emergent BioSolutions, Inc., Johnson and Johnson, Sanofi Pasteur, Inc., Pfizer, Inc., Novartis AG, CSL Ltd., and GlaxoSmithKline Plc. Other prominent players include Abbott Laboratories, Inc., AstraZeneca plc, Janssen Pharmaceuticals, Inc., Takeda Pharmaceuticals Company Ltd., and Valeant Pharmaceuticals International, Inc.
  • In April 2016, VBI vaccines, Inc. entered into a collaborative agreement with Sanofi Pasteur, Inc. to employ its “Lipid Particle Vaccine” formulation technology to better the stability of the Sanofi vaccines. 
View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/biotechnology
Grand View Research has segmented the Global Vaccines Market on the basis of type, application, and region:
Global Vaccines Market By Type (Revenue, USD Million, 2013 - 2024)
  • Inactivated vaccines
  • DNA vaccines
  • Attenuated vaccines
  • Subunit vaccines
  • Conjugate vaccines
  • Toxoid vaccines
  • Others
Global Vaccines Market By Application (Revenue, USD Million, 2013 - 2024)
  • Infectious diseases
  • Cancer
  • Autism
  • Allergy
  • Others
Vaccines Market By Region (Revenue, USD Million, 2013 - 2024)
  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
  • Asia Pacific
    • Japan
    • China
  • Latin America
    • Brazil
  • MEA
    • South Africa
View press release of this research report by Grand View Research: 

About Grand View Research 
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: www.grandviewresearch.com


at No comments:

Automotive Radar Market Projected to reach USD 12.16 billion by 2025 : Grand View Research,Inc.

Global Automotive Radar Market is expected to reach USD 12.16 billion by 2025, growing at a CAGR of 20.8%, according to a study conducted by Grand View Research, Inc. The growing focus on active safety features, innovations in the radar technology, decreasing prices of components, and increasing sales of vehicles are the propelling factors for market growth. Radars play a vital role in detecting objects in various safety systems including adaptive cruise control, pedestrian detection system, blind spot detection, and automated emergency braking.
In order to achieve complete vehicle autonomy, it is essential for automakers to focus on the enhancement of the radar technology and subsequently on the reduction in the size of radar systems. One of the major hurdles hampering the growth of automotive radars is the lack of uniform frequency allocation across the globe. Moreover, the use of higher frequency band is likely to lead to higher resolution benefits and promote the use of a single technology for all applications, thereby reducing the risk of mutual interference. The European Commission has already initiated the 79 GHz project for vehicular radars, which has been the foundation for the future development of the automotive radar market.
The market is characterized by the presence of prominent automotive electronics manufacturers including Continental AG, Robert Bosch GmbH, Infineon Technologies AG, and Texas Instruments, among others. Strong R&D capabilities have led to the development of application-oriented radars. Additionally, they have assisted radar manufacturers in complying with different frequency standards present in different countries.
According to the World Health Organization, globally 1.25 million people suffer from death due to road traffic crashes each year. Road accidents are likely to become the seventh leading cause of death by 2030 if appropriate measures to increase vehicle safety are not taken. Thus, the need to protect drivers and passengers from potential accidents would play an important role in determining the growth of the automotive radar market.
Full Research Report on Global Automotive Radar Market Analysis: 

Further key findings from the study suggest:
  • Medium & short range radar is the fastest growing segment in terms of range, owing to their growing use in numerous applications, such as blind spot detection, lane change assist, and park assist, among others.
  • In terms of vehicle types, the passenger car segment is projected to drive the market, owing to the rising radar-based safety systems in mid-priced passenger cars.
  • Adaptive Cruise Control (ACC) is projected to hold the largest market size by 2025 owing to rising safety concerns among growing automotive markets such as India and China.
  • Increasing efforts from the National Highway Traffic Safety Administration (NHTSA), the Insurance Institute for Highway Safety, and prominent automakers operating in the U.S. for mandating the installation of AEBs in all cars by 2022 are likely to boost the automotive radar market.
  • The European region held the largest market size in 2016, which is attributed to the increased stringency in safety norms and NCAP rating.
  • The Asia Pacific region is projected to grow at the highest CAGR owing to the rapid adoption of radar-based safety features and increasing vehicle production.
View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/automotive-and-transportation
Grand View Research has segmented the Global Automotive Radar Market on the basis of range, vehicle type, application, and region:
Range Outlook (Revenue, USD Million; 2014 - 2025)
  • Long Range
  • Medium & Short Range
Vehicle Type Outlook (Revenue, USD Million; 2014 - 2025)
  • Passenger Cars
  • Commercial Vehicles
Application Outlook (Revenue, USD Million; 2014 - 2025)
  • Adaptive Cruise Control (ACC)
  • Autonomous Emergency Braking (AEB)
  • Blind Spot Detection (BSD)
  • Forward Collision Warning (FCW)
  • Intelligent Park Assist
  • Other ADAS Systems     
Regional Outlook (Revenue, USD Million; 2014 - 2025)
  • North America
    • U.S.
    • Mexico
    • Canada
  • Europe
    • UK
    • Germany
  • Asia Pacific
    • China
    • India
    • Japan
  • South America
    • Brazil
View press release of this research report by Grand View Research: 

About Grand View Research 
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information: www.grandviewresearch.com
at No comments:
Labels: , ,

Pharmaceutical Packaging Market Projected to reach USD 158.8 billion by 2025 : Grand View Research,Inc.

Global Pharmaceutical Packaging Market is expected to reach USD 158.8 billion by 2025, according to a new report by Grand View Research, Inc. The growing demand for pharmaceuticals coupled with increased emphasis on product packaging is expected to drive market growth.
Pharmaceutical packaging market comprises wide array of products. The demand for these products is expected to grow rapidly on account of fortification of medicines and drugs against exterior impacts. However, the packaging materials and products need to bear the brunt of stringent government regulations and growing market for counterfeit pharmaceuticals. Counterfeit pharmaceuticals are expected to pose a major threat to manufacturers.
North America is a dominant region in the market backed by thriving pharmaceutical industry and rapid new product introduction. Asia Pacific is anticipated to grow rapidly on account of rising pharmaceutical manufacturing in China and India. The growing trend of contract packaging in the pharmaceutical industry is expected to further augment market growth in Asia Pacific.
Full Research Report on Global Pharmaceutical Packaging Market Analysis: 

Further key findings from the report suggest:
  • Aluminum foil material segment is projected to grow at a CAGR of 7.2% from 2017 to 2025 owing to rising demand for packaging of special purpose drugs.
  • Paper and paperboard is the second largest product segment and is expected to reach USD 40.83 billion by 2025 due to growing demand in secondary packaging products.
  • Blister packs in the primary pharmaceutical packaging product category is expected to grow at a CAGR of 9.2% from 2017 to 2025 on account of growing demand in oral drugs.
  • The market share of Asia Pacific is expected to reach 33% in 2025 owing to growing demand for pharmaceuticals and presence of large number of plastic manufacturers
  • The Middle East & Africa region is expected to grow at a CAGR of 5.6% from 2017 to 2025 backed by growing demand for medicines in Tanzania, Nigeria and South Africa.
  • The market is highly dispersed due to the presence of a large number of small and large manufacturers
View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/pharmaceuticals
Grand View Research has segmented the Global Pharmaceutical Packaging Market on the basis of material, product, end-use and region:
Pharmaceutical Packaging Material Outlook (Revenue, USD Billion, 2014 - 2025)
  • Plastics & Polymers
    • HDPE
    • Polyester
    • LDPE
    • PVC
  • Paper & Paperboard
  • Glass
  • Aluminum Foil
  • Others
Pharmaceutical Packaging Product Outlook (Revenue, USD Billion, 2014 - 2025)
  • Primary Packaging
    • Plastic Bottles
    • Caps & Closures
    • Parenteral Containers
    • Blister Packs
    • Prefillable Inhalers
    • Pouches
    • Medication Tubes
    • Others
  • Secondary Packaging
    • Prescription Containers
    • Pharmaceutical Packaging Accessories
  • Tertiary Packaging
Pharmaceutical Packaging End-use Outlook (Revenue, USD Billion, 2014 - 2025)
  • Pharmaceutical Manufacturing
  • Contract Packaging
  • Retail Pharmacy
  • Institutional Pharmacy
  • Others
Pharmaceutical Packaging Regional Outlook (Revenue, USD Billion, 2014 - 2025)
  • North America
    • U.S.
  • Europe
    • Germany
    • France
  • Asia Pacific
    • China
    • India
    • Japan
  • Central & South Africa
    • Brazil
  • Middle East & Africa
View press release of this research report by Grand View Research: 

About Grand View Research 
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: www.grandviewresearch.com



at No comments:
Labels: , ,
Subscribe to: Posts (Atom)